Announcements Trials

Browse Landscape

Status

Completed 2 Withdrawn 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 2 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Kidney Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Docetaxel 11 Prednisone 10 Leuprolide 10 Magnetic Resonance Spectroscopy 9 bicalutamide 8 Radiotherapy 7 Abiraterone Acetate 7 Biopsy 6 gallium 68 PSMA-11 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5 Surveys and Questionnaires 5 Metformin 5 Goserelin 5 radium Ra 223 dichloride 4 enzalutamide 4 apalutamide 4 Specimen Handling 4 Injections 4 Androgen Antagonists 4 pembrolizumab 3 orteronel 3 cabazitaxel 3 abiraterone 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 Pioglitazone 3 Paclitaxel 3 Exercise 3 Brachytherapy 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Prostatic Neoplasms × Radiofrequency Ablation × Clear all

NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡